LLY

1,031.85

-1.94%↓

JNJ

244.39

-0.83%↓

ABBV

228.56

+0.18%↑

NVS

167.5

+0.02%↑

MRK

122.86

-0.94%↓

LLY

1,031.85

-1.94%↓

JNJ

244.39

-0.83%↓

ABBV

228.56

+0.18%↑

NVS

167.5

+0.02%↑

MRK

122.86

-0.94%↓

LLY

1,031.85

-1.94%↓

JNJ

244.39

-0.83%↓

ABBV

228.56

+0.18%↑

NVS

167.5

+0.02%↑

MRK

122.86

-0.94%↓

LLY

1,031.85

-1.94%↓

JNJ

244.39

-0.83%↓

ABBV

228.56

+0.18%↑

NVS

167.5

+0.02%↑

MRK

122.86

-0.94%↓

LLY

1,031.85

-1.94%↓

JNJ

244.39

-0.83%↓

ABBV

228.56

+0.18%↑

NVS

167.5

+0.02%↑

MRK

122.86

-0.94%↓

Home・Aandelen Lijst・CorMedix Inc

CorMedix Inc

Open

SectorGezondheidszorg

7.27 3.27

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

7.27

Belangrijke statistieken
By Trading Economics
Inkomsten	89M 109M
Verkoop	65M 104M
K/W Sectorgemiddelde	3.172 108.767
Winstmarge	104.112
Werknemers	64
EBITDA	37M 57M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+95.01% upside

Dividenden
By Dow Jones
Volgende Winsten	24 mrt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-316M 552M
Vorige openingsprijs	4
Vorige sluitingsprijs	7.27

Nieuwssentiment

By Acuity

54%

46%

288 / 351 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

9.2 / N/A Steun & Weerstand

CorMedix Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 feb 2026, 23:07 UTC

Winsten

Woolworths 1st Half Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 feb 2026, 23:01 UTC

Winsten

Fortescue 1st Half Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 feb 2026, 22:59 UTC

Winsten

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability -- Update

24 feb 2026, 22:42 UTC

Winsten

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability

24 feb 2026, 22:24 UTC

Acquisities, Fusies, Overnames

Warner Bros. Discovery Board Says Paramount Skydance's New Proposal Could Top Netflix Agreement -- Update

24 feb 2026, 23:46 UTC

Marktinformatie

Gold Edges Higher Amid Possible Position Adjustments -- Market Talk

24 feb 2026, 23:36 UTC

Marktinformatie

Nikkei May Rise, Tracking Wall Street's Rebound -- Market Talk

24 feb 2026, 23:30 UTC

Marktinformatie

Fortescue's Copper Bet Is Long Term, While Iron Ore Remains Near-Term Driver -- Market Talk

24 feb 2026, 23:20 UTC

Marktinformatie

Fortescue Dividend Beat Overshadows Profit Miss -- Market Talk

24 feb 2026, 23:20 UTC

Marktinformatie

Global Equities Roundup: Market Talk

24 feb 2026, 23:16 UTC

Winsten

Oversea-Chinese Banking Corp.'s CEO: "Looking Ahead, We Remain Cautious Yet Positive">O39.SG

24 feb 2026, 23:13 UTC

Winsten

Oversea-Chinese Banking Corp. FY25 Non-Interest Income S$5.46B Vs. S$4.72B >O39.SG

24 feb 2026, 23:12 UTC

Winsten

Oversea-Chinese Banking Corp.: FY25 Net Interest Income S$9.15B Vs. S$9.76B>O39.SG

24 feb 2026, 23:10 UTC

Winsten

Oversea-Chinese Banking Corp. FY25 NPL Ratio 0.9%, Unchanged on Year>O39.SG

24 feb 2026, 23:10 UTC

Winsten

Oversea-Chinese Banking Corp. FY25 Net Interest Margin 1.91%, Down 29bps on Year>O39.SG

24 feb 2026, 23:08 UTC

Winsten

Oversea-Chinese Banking Corp. FY25 Net S$7.42B Vs. Net S$7.59B >O39.SG

24 feb 2026, 23:07 UTC

Winsten

Oversea-Chinese Banking Corp. FY25 Total Income S$14.61B Vs. S$14.47B>O39.SG

24 feb 2026, 22:52 UTC

Winsten

Woolworths 1H Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 feb 2026, 22:46 UTC

Winsten

Fortescue 1H Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 feb 2026, 22:31 UTC

Acquisities, Fusies, Overnames

Warner Receives New Bid From Paramount -- 3rd Update

24 feb 2026, 22:29 UTC

Winsten

Woolworths: FY Ebit Growth for Australian Food Expected at Upper End of Mid-to-High Single Digit Range Provided in August

24 feb 2026, 22:28 UTC

Winsten

Woolworths: Australian Food Current Growth Rates Reflect Some Benefit from Cycling of Industrial Action Impacts

24 feb 2026, 22:27 UTC

Winsten

Woolworths: Australian Food Sales +7.2% Excluding Tobacco in 2H First Seven Weeks

24 feb 2026, 22:27 UTC

Winsten

Woolworths: Australian Food Sales +5.8% in 2H First Seven Weeks

24 feb 2026, 22:25 UTC

Winsten

Woolworths: Customers Continue to be Value-Focused, Shopping Multiple Retailers in Highly Competitive Environment

24 feb 2026, 22:24 UTC

Winsten

Woolworths: Trading in 3Q to Date Has Been Strong in Australian Food

24 feb 2026, 22:23 UTC

Winsten

Woolworths 1H Group Sales A$37.1 Bln, Up 3.4%

24 feb 2026, 22:22 UTC

Winsten

Woolworths Interim Dividend 45 Australian Cents/Share

24 feb 2026, 22:22 UTC

Winsten

Woolworths 1H Profit Before Significant Items A$859 Mln, Up 16.4%

24 feb 2026, 22:21 UTC

Winsten

Woolworths 1H Statutory Net Profit A$374 Mln, Down 49.4%

Peer Vergelijking

Prijswijziging

CorMedix Inc Prognose

Koersdoel

By TipRanks

95.01% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 13.67 USD 95.01%

Hoogste 15 USD

Laagste 13 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor CorMedix Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

4 ratings

Buy

Hold

Sell

Gebaseerd op 4 analisten die aandelenratings hebben gegeven aan CorMedix Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

9.2 / N/ASteun & Weerstand

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

288 / 351 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.